Robert M. Jones,Sangdon Han,Juerg Lehmann,Lars Thoresen
申请号：
US14007759
公开号：
US20140018371A1
申请日:
2012.03.30
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as a single agent or in combination with one or more pharmaceutical agents, such as, an inhibitor of DPP-IV, a biguanide, or an alpha-glucosidase inhibitor, in the treatment of, for example, a disorder selected from: a GPR119-receptor-related disorder a condition ameliorated by increasing a blood incretin level a metabolic-related disorder type 2 diabetes obesity and complications related thereto.
